Literature DB >> 11099700

Effects of nitric oxide synthase inhibitor N(G)-nitro-L-arginine methyl ester on phencyclidine-induced effects in rats.

M Bujas-Bobanovic1, H A Robertson, S M Dursun.   

Abstract

Phencyclidine (PCP) is widely used as an animal model of schizophrenia. In rats, acute PCP treatment increased locomotor activity and induced stereotyped behaviours consisting of head weaving, turning and backpedalling. PCP had differential regional effects on c-fos expression in rat brain, suggesting different patterns of neuronal activity. The most prominent immunostaining was observed in the cortical regions. To elucidate the role of nitric oxide, an important intracellular messenger, in the mechanism of action of PCP the effects of nitric oxide synthase inhibitor N(G)-nitro-L-arginine methyl ester (L-NAME) were studied in PCP-treated animals. L-NAME potentiated PCP-induced behaviours and c-fos expression in many brain regions. The greatest increases were observed in the frontal, retrosplenial granular cortex, cerebellum, thalamic and subthalamic nuclei. While PCP alone induced low c-fos expression in the entorhinal cortex, with almost no expression in the rostral part of caudate putamen, animals pretreated with L-NAME showed marked activation in these brain areas. These results strongly indicate the involvement of the nitric oxide system in the mechanism of action of PCP.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11099700     DOI: 10.1016/s0014-2999(00)00830-x

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  7 in total

1.  Testing the validity of c-fos expression profiling to aid the therapeutic classification of psychoactive drugs.

Authors:  B E H Sumner; L A Cruise; D A Slattery; D R Hill; M Shahid; B Henry
Journal:  Psychopharmacology (Berl)       Date:  2003-09-10       Impact factor: 4.530

2.  Involvement of NO/cGMP pathway in toluene-induced locomotor hyperactivity in female rats.

Authors:  Ming-Huan Chan; Te-Hsiung Chien; Pei-Yu Lee; Hwei-Hsien Chen
Journal:  Psychopharmacology (Berl)       Date:  2004-04-29       Impact factor: 4.530

3.  Imbalanced free radicals and antioxidant defense systems in schizophrenia: a comparative study.

Authors:  Hui-chun Li; Qiao-zhen Chen; Ying Ma; Jun-fu Zhou
Journal:  J Zhejiang Univ Sci B       Date:  2006-12       Impact factor: 3.066

4.  Activation of a nitric-oxide-sensitive cAMP pathway with phencyclidine: elevated hippocampal cAMP levels are temporally associated with deficits in prepulse inhibition.

Authors:  Daniel Klamer; Erik Pålsson; Kim Fejgin; Jianhua Zhang; Jörgen A Engel; Lennart Svensson
Journal:  Psychopharmacology (Berl)       Date:  2004-12-24       Impact factor: 4.530

5.  Plasma nitrate levels in deficit versus non-deficit forms of schizophrenia.

Authors:  Eiji Suzuki; Toshio Nakaki; Makoto Nakamura; Hitoshi Miyaoka
Journal:  J Psychiatry Neurosci       Date:  2003-07       Impact factor: 6.186

6.  Inducible Nitric Oxide Inhibitors Block NMDA Antagonist-Stimulated Motoric Behaviors and Medial Prefrontal Cortical Glutamate Efflux.

Authors:  Hadley C Bergstrom; Altaf S Darvesh; S P Berger
Journal:  Front Pharmacol       Date:  2015-12-15       Impact factor: 5.810

Review 7.  Potential role of amino acids in pathogenesis of schizophrenia.

Authors:  Shamaila Saleem; Faiza Shaukat; Anjuman Gul; Mahwish Arooj; Arif Malik
Journal:  Int J Health Sci (Qassim)       Date:  2017 Jul-Sep
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.